Preview Mode Links will not work in preview mode

Jun 19, 2026

Ibogaine is regularly categorized as a psychedelic β€” but that label may be misleading in ways that matter. In this micro, James offers a crash course in what ibogaine actually is: where it comes from, how its unusual pharmacology works, what it does to the mind, and why it holds a position in addiction medicine that no other drug on earth can claim. The risk profile is part of the picture too.

This is a clip from 'Psychedelics in Research & Practice | James W. Jesso', Adventures Through The Mind Podcast, episode 200

FULL EPISODE

MORE IBOGAINE EPISODES

SUPPORT THE PODCAST

πŸ₯° Support ATTMind and join the community on Patreon

Other options

Connect with Me

EPISODE BREAKDOWN AND TIMESTAMPS

  • (00:00) β€” What is ibogaine?
  • (00:43) β€” An oneirogen, not a psychedelic
  • (01:33) β€” Closed-eye visuals and the life review
  • (02:02) β€” Pharmacological complexity: the "14th century key" metaphor
  • (04:39) β€” Duration and physical challenges of the experience
  • (06:34) β€” Cardiac risk: the only psychedelic that can directly cause death
  • (09:01) β€” Encountering ancestors and the Bwiti tradition
  • (09:51) β€” A brief history: from West Africa to underground use
  • (10:58) β€” Stopping opioid addiction in a single session
  • (12:21) β€” The current treatment landscape
  • (14:44) β€” Reversing traumatic brain injury: the Stanford research
  • (18:47) β€” Brain de-aging and multiple sclerosis potential
  • (19:53) β€” Outro